Barclays
ALHC icon

Barclays’s Alignment Healthcare ALHC Stock Holding History

Barclays’s Portfolio ALHC Stock Details ALHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.67M Buy
940,243
+835,162
+795% +$12.5M ﹤0.01% 1806
2026
Q2 		$2.5M Buy
105,081
+38,605
+58% +$741K ﹤0.01% 2223
2026
Q1 		$1.17M Sell
66,476
-603,057
-90% -$12.1M ﹤0.01% 2663
2025
Q4 		$13.2M Sell
669,533
-678,201
-50% -$12.2M ﹤0.01% 1490
2025
Q3 		$23.5M Sell
1,347,734
-869,430
-39% -$12.9M 0.01% 1136
2025
Q2 		$31M Buy
2,217,164
+1,348,143
+155% +$21.7M 0.01% 903
2025
Q1 		$16.2M Buy
869,021
+668,457
+333% +$10M ﹤0.01% 1138
2024
Q4 		$2.26M Buy
200,564
+7,118
+4% +$83.2K ﹤0.01% 2787
2024
Q3 		$2.29M Buy
193,446
+114,191
+144% +$1.08M ﹤0.01% 2751
2024
Q2 		$620K Sell
79,255
-59,766
-43% -$390K ﹤0.01% 2908
2024
Q1 		$690K Sell
139,021
-43,787
-24% -$280K ﹤0.01% 3378
2023
Q4 		$1.57M Buy
182,808
+94,498
+107% +$691K ﹤0.01% 3107
2023
Q3 		$613K Buy
88,310
+26,383
+43% +$159K ﹤0.01% 2672
2023
Q2 		$356K Sell
61,927
-620
-1% -$4.01K ﹤0.01% 2950
2023
Q1 		$398K Buy
62,547
+23,212
+59% +$221K ﹤0.01% 3420
2022
Q4 		$463K Buy
39,335
+22,935
+140% +$279K ﹤0.01% 3364
2022
Q3 		$194K Sell
16,400
-9,818
-37% -$143K ﹤0.01% 3229
2022
Q2 		$299K Sell
26,218
-5,745
-18% -$60.6K ﹤0.01% 3198
2022
Q1 		$359K Buy
+31,963
New +$288K ﹤0.01% 3099

Other funds holding ALHC

William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Barclays's ALHC Position: Q3 2026 in Review

Barclays increased its Alignment Healthcare (ALHC) stake by 795% in Q3 2026, buying an estimated $12.5M and bringing the position to 940,243 shares worth $7.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1806.

Barclays first reported a position in ALHC in Q1 2022 and has held it in 19 quarters since. The position peaked at $31M in Q2 2025. 118 funds tracked by Wall St. Rank hold ALHC as of Q3 2026.

  • Barclays held 940,243 shares of Alignment Healthcare worth $7.67M as of Q3 2026.
  • Barclays bought 835,162 Alignment Healthcare shares in Q3 2026, an estimated $12.5M.
  • Alignment Healthcare made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #1806 holding.
  • Barclays first reported a position in Alignment Healthcare in Q1 2022 and has held it in 19 quarters since.
  • Barclays's Alignment Healthcare position peaked at $31M in Q2 2025.
  • 118 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.